Intranasal Da Chuanxiong formula alleviates vestibular migraine-like phenotypes via modulation of DRD2/TRPV1-associated signaling

Identifying novel pharmacological targets (DRD2/TRPV1) for vestibular migraine may inspire future drug development relevant to a condition with limited treatment options.